Cipher Pharmaceuticals Inc's stock has seen a modest decline this week, reflecting broader market sentiments.
This week, Cipher Pharmaceuticals Inc (CPH.TO) has experienced slight downward pressure, closing at C$14.12 on Thursday, marking a 1.79% decrease for the day and a 1.65% decline over the week. Despite some recent positive headlines regarding its financial performance, investor sentiment appears cautious as the company navigates its financial landscape.
Advertisement
Cipher Pharmaceuticals Inc
CPH.TO
CPH.TO
Cipher Pharmaceuticals Inc
WealthAwesomeMarket cap
$362.67M
P/E
9.1x
52W high
$20.56
52W low
$12.48
1W change
-1.65%
Beta
0.40
Analyst Price Targets
Based on analyst covering CPH · as of Sep 23, 2026
Wall Street analysts forecast CPH stock price to rise 36.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$19.45
+36.3% Upside
Previously C$19.95 on Sep 17, 2026
Current Price
C$14.27
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CPH's historical volatility
30-Day Vol
73.7%
Annualized
90-Day Vol
46.4%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$11.94
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$13.45 | C$10.43 – C$17.34 |
| 60 trading days | C$12.67 | C$8.84 – C$18.15 |
| 90 trading days | C$11.94 | C$7.69 – C$18.54 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Cipher Pharmaceuticals has shown resilience in its financials, but recent stock performance suggests investors are weighing potential risks against the backdrop of its recent earnings reports. With a solid profit margin and positive analyst outlook, the company may still hold long-term potential, but short-term volatility could persist.
Cipher Pharmaceuticals Inc's stock closed at C$14.12, down 1.79% on the day.
The stock has been trading within a 52-week range of C$12.48 to C$20.56, indicating a potential for recovery but also highlighting recent volatility.
Bull case
Cipher's recent announcements of record financial results for 2025 and a court ruling affirming its ownership of key clinical data may boost investor confidence. The company boasts a strong profit margin of 58.4% and a low beta of 0.40, suggesting it is less volatile than the market. This stability can be appealing during uncertain times.
Bear case
The recent decrease in net income reported for Q2 2026 and the decline in total revenue compared to last year could raise concerns among investors. Additionally, the stock is currently trading below both its 50-day and 200-day moving averages, which may signal potential weakness in market sentiment.
Recent Price Action
Advertisement
Cipher Pharmaceuticals Inc (CPH.TO) closed at C$14.12 on Thursday, reflecting a daily decline of 1.79%. For the week, the stock is down 1.65%, while it has shown a slight increase of 1.21% over the past month. Year-to-date, Cipher's stock has decreased by 4.23%, indicating a challenging environment for the company amidst fluctuating investor sentiment.
Company News and Headlines
While there have been no new major announcements from Cipher Pharmaceuticals this week, several recent headlines have highlighted the company’s financial performance. Notably, Cipher reported record revenue for the fiscal year 2025, achieving $50.5 million, a 51% increase over the previous year. However, the company also reported a decrease in net income for Q2 2026, which may contribute to the cautious sentiment observed in the stock's performance.
Technical Picture
From a technical perspective, Cipher's stock is currently trading below its 50-day moving average of C$15.28 and its 200-day moving average of C$15.99, indicating potential selling pressure. The stock has a beta of 0.40, suggesting it is less volatile than the broader market. The current volume of 10,169 shares is below the 20-day average volume of 26,875 shares, reflecting lower trading activity.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
